More than 25 million Americans suffer from daily chronic pain, a highly debilitating medical condition that is complex and difficult to manage. In recent decades, there has been an overreliance in the prescription of opioids for chronic pain despite their poor ability to improve function and high addiction liability. This contributed to a significant and alarming epidemic of opioid overdose deaths and addictions. Innovative scientific solutions to develop alternative pain treatment options are thus critically needed. Through targeted research efforts, the NIH HEAL Initiative aims to support the development of safe and effective devices to treat pain with little or no addiction liability. This funding opportunity announcement (FOA) is designed to support interdisciplinary research teams of multiple PD/PIs to investigate the mechanism of action of pain relief by medical devices with the overall goal of optimizing therapeutic outcomes for FDA-approved or -cleared technologies. Program teams are expected to accomplish goals that require considerable synergy and collaborative interactions. Teams must leverage appropriate multi-disciplinary expertise to develop new principles and methods for experimentation, analysis, and interpretation. Teams are encouraged to consider objectives that will produce major advances in the field of pain relief by medical devices.
Grantor contact
HHS-NIH11
Administering federal agency
Funding summary
93.121
Oral Diseases and Disorders Research
93.213
Research and Training in Complementary and Integrative Health
93.273
Alcohol Research Programs
93.279
Drug Abuse and Addiction Research Programs
93.393
Cancer Cause and Prevention Research
93.846
Arthritis, Musculoskeletal and Skin Diseases Research
93.847
Diabetes, Digestive, and Kidney Diseases Extramural Research
93.853
Extramural Research Programs in the Neurosciences and Neurological Disorders
93.865
Child Health and Human Development Extramural Research
93.866
Aging Research
93.867
Vision Research